New drug duo tested for Tough-to-Treat lung cancer
NCT ID NCT03083041
Summary
This study tested a combination of two drugs, SHR-1210 and apatinib, for people with advanced non-small cell lung cancer whose cancer had grown after standard chemotherapy. The main goals were to see how safe the combination was and how well it worked to shrink tumors. It involved 210 participants and tested two different doses of apatinib alongside the SHR-1210 treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, NON-SMALL-CELL LUNG are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, 200433, China
Conditions
Explore the condition pages connected to this study.